M2 |
LUAD (H1395 and H197) |
Macrophage—lung cancer cells |
Conditioned media was added (exosomes or free secreted factors) |
N/A |
CXCL17 |
Stimulation of spine metastasis |
(72) |
M2 |
NSCLC |
Lung cancer cells—Macrophage |
N/A |
N/A |
p38 (p-p38) which further increases HIF-1α |
Hypoxia induces M2 polarization through p38 |
(73) |
M2 |
Lewis lung carcinoma |
Macrophage—lung cancer cells |
Chemokine receptors CCR2 and CX3CR1 chemokine receptor |
IL-1, MIP1α0, IL-6, CCL1, G-CSF upregulated in the system |
CCR2 and CX3CR1 upregulation after IL-10 or MIP1α exposure, upregulation of MMPs, GF, VEGF |
Aggressiveness of lung cancer cell increased more in direct contact with macrophage than in non-contact culture |
(68) |
M2 |
SCLC |
Macrophage—lung cancer cells |
Non-contact cell culture, culture media, soluble factors |
IL-6 |
STAT3 activation |
Lung cancer cell proliferation and invasion |
(69) |
TAMs |
NSCLC |
Macrophage—lung cancer cells |
Contact in vivo tumor |
TNF-α |
Depletion of TAMs resulted in decreased GLUT1, PDK1, PDH, PGK, HK2, G6P, VEGFA, CA-9, NOS2; PD-L1 |
Increased glycolysis in cancer cells, decreased infiltrated T cells |
(71) |
M1/M2 |
Lewis lung carcinoma |
Macrophage (M2)—lung cancer cells |
Non-contact cell culture, culture media, soluble factors |
pAMK |
Upregulation of AMPKα in the M2 macrophage |
Migration/invasion |
(74) |
SIRPα expressing macrophage |
SCLC |
Lung cancer cells—Macrophage |
Direct contact through antigen (CD47—tumor) and receptor (SIRPα–macrophage) |
N/A |
|
M2-like phenotype, without capacity of phagocytosis |
(56) |
M2 |
NSCLC |
Macrophage—lung cancer cells |
Secreted cytokines in the culture media (IL-10) |
IL-10 |
SOX2, Oct4, c-Myc, Vimentin, N-CAD - upregulation, phosphorylation of JAK1, STAT1/STAT3/STAT6, NOTCH1 |
Cancer stemness and EMT |
(58) |
M2 |
NSCLC |
Macrophage—lung cancer cells |
Secreted cytokines in the culture media IL-6 |
IL-6 |
E-CAD downregulation, VIM upregulation, β-catenin translocation in the nucleus, COX2, PGE2 upregulation |
EMT |
(70) |
M2 |
NSCLC |
Lung cancer cells—Macrophage |
Supernatant from cancer cells |
IL-34 |
Binding to the CSF-1R receptor, IL-10, and TGF-β overexpression |
Polarization to anti-inflammatory phenotype, forms a feedback loop with cancer cells to sustain chemoresistance |
(60) |
M1 |
Murine lung carcinoma cell lines (LLC26 and CMT 167) |
Lung cancer cells—Macrophage |
N/A |
N/A |
N/A |
The lack of Caveolin-2 enhances local polarization of M1 macrophage, which further stimulates the local acquisition of CD8+ and CD4+ T cells, leading to smaller tumors |
(67) |